Q2 2025 ICON PLC Earnings Call Transcript
Key Points
- Icon PLC (ICLR) reported an 11% sequential increase in gross business awards, driven by notable wins from biotech customers and large pharma partnerships.
- Revenue performance exceeded expectations, aided by higher pass-through revenue, resulting in a stable burn rate of 8.2% for the quarter.
- Adjusted EBITDA margin improved to 19.6%, with gross margin increasing to 28.3% and SG&A costs reduced by $9 million year-over-year.
- The company launched a center for obesity, enhancing its capabilities in a rapidly growing therapeutic area, with a network of over 100 US sites.
- Icon PLC (ICLR) repurchased $250 million in shares and expanded its share repurchase authorization to $1 billion, reflecting strong financial discipline and shareholder return focus.
- The net book-to-bill ratio was negatively impacted by elevated cancellations, including the cancellation of a large next-generation COVID vaccine trial.
- Revenue decreased by 4.8% year-over-year, with adjusted gross margin slightly down compared to the previous year.
- The company anticipates continued elevated cancellations in the near term, which could impact future net bookings.
- Despite a constructive market outlook, the environment remains volatile and uncertain, particularly in the biotech funding landscape.
- Increased pricing competition in the market could pressure margins, requiring Icon PLC (ICLR) to maintain cost efficiencies.
Good day and thank you for standing by. Welcome to the ICON PLC Q2 2025 earnings conference call. At this time, all participants are in a listen-only mode. (Operator Instructions) Please be advised today's conference is being recorded.
I'd now like to hand the conference over to your first speaker today, Kate Haven. Please go ahead.
Good day and thank you joining us on this call covering the quarter ended June 30, 2025. Also, on the call today, we have our CEO, Dr. Steve Cutler --
Kate are now live, please go ahead.
Can you hear me? Good day and thank you for joining us on this call covering the quarter ended June 30, 2025. Also, on the call today, we have our CEO, Dr. Steve Cutler; our CFO, Nigel Clerkin.
Hello, operator.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
